D

Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192

Watchlist Manager
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Watchlist
Price: 45.34 CNY -1.82% Market Closed
Market Cap: 18.8B CNY
Have any thoughts about
Dizal Jiangsu Pharmaceutical Co Ltd?
Write Note

Dizal Jiangsu Pharmaceutical Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dizal Jiangsu Pharmaceutical Co Ltd
Capital Expenditures Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
D
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Capital Expenditures
-ÂĄ32.1m
CAGR 3-Years
47%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Capital Expenditures
-ÂĄ4.1B
CAGR 3-Years
-61%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Capital Expenditures
-ÂĄ1.2B
CAGR 3-Years
-44%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Capital Expenditures
-ÂĄ497.9m
CAGR 3-Years
-26%
CAGR 5-Years
-39%
CAGR 10-Years
-20%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Capital Expenditures
-ÂĄ1B
CAGR 3-Years
14%
CAGR 5-Years
-14%
CAGR 10-Years
-16%
Imeik Technology Development Co Ltd
SZSE:300896
Capital Expenditures
-ÂĄ63.7m
CAGR 3-Years
-26%
CAGR 5-Years
-10%
CAGR 10-Years
N/A

See Also

What is Dizal Jiangsu Pharmaceutical Co Ltd's Capital Expenditures?
Capital Expenditures
-32.1m CNY

Based on the financial report for Dec 31, 2023, Dizal Jiangsu Pharmaceutical Co Ltd's Capital Expenditures amounts to -32.1m CNY.

What is Dizal Jiangsu Pharmaceutical Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-21%

Over the last year, the Capital Expenditures growth was 56%. The average annual Capital Expenditures growth rates for Dizal Jiangsu Pharmaceutical Co Ltd have been 47% over the past three years , -21% over the past five years .

Back to Top